AzTrials
AzTrials

Healthy VolunteersNCT06173635

A Comparison Study of the Maxi Move 5 (MM5) Device

A study testing Maxi Move 5 in people with Healthy Volunteers, run by Arjo AB at 1 site in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This trial aims to evaluate the added improvements from a caregiver and patient benefit perspective. The trial should identify the forces involved for the caregiver when manoeuvring the lift. Read more about this study

Who is it for?
Ages 18 to 85 yearsHealthy volunteers can take part
Conditions the study is for
Healthy Volunteers
What is being tested?
Maxi Move 5
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
21 participants
Where
1 siteUnited Kingdom
Study dates
20 Dec 2023to 31 May 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 85 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • For expert patient:
  • ≥18 years
  • Healthy male or female
  • 80-100 kg
  • 24 healthy volunteers (caregivers) will be recruited. They will require a strong working knowledge of passive floor lifts and patient positioning with the use of loop and clip slings.

Who cannot join

  • -

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • School of Design and Creative Art at Loughborough University

    Loughborough

Other trials in United Kingdom

About this study

Official title: A Laboratory Trial to Explore the Benefits of the New Maxi Move 5 (MM5) Technology

This trial aims to evaluate the added improvements from a caregiver and patient benefit perspective.

The trial should identify the forces involved for the caregiver when manoeuvring the lift.

Being tested
Maxi Move 5

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Maxi Move 5Device

    4 comparative devices will be used to evaluate the MM5 device

Study groups in NCT06173635
Study groupRoleWhat they receive
Maxi Move 5Other24 healthy volunteers will evaluate all 5 devices
Receives: Device: Maxi Move 5

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. 1. Time to complete each transfer will be recorded

    Time to complete each activity and each task within the activity will be measured in seconds.

    Measured: up to 24 months

  2. 2. A detailed hierarchical task analysis (HTA) of each activity will be completed using the video recordings and experimenter field notes for each transfer to asses the number of correct placements for each device.

    Correct placement will be visually controlled with the use of markers on the subject and the final positioning device (e.g chair, toilet or bed) for each transfer. This will be reported as distance from the ideal position.

    Measured: up to 24 months

  3. 3. Physical load for movement of the hoist throughout the activities for each device will be measured.

    Force required to complete the range of patient and hoist positioning tasks, forward, backwards, rotation movement, patient positioning etc. These forces will be used with the HTA data to calculate the amount of physical force delivered by the participants with each device and each transfer. The forces used will be presented in newton.

    Measured: up to 24 months

  4. 4 Collect subjective data from the caregivers that describe, comfort, ease of use, effort and willingness to adopt in practice, etc

    This will be collected by the use of questionnaires

    Measured: up to 24 months

  5. 5 Subjective responses from the expert patient being transferred will be recorded

    This will be collected by the use of questionnaires

    Measured: up to 24 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Dec 2023
  2. Study start20 Dec 2023
  3. Primary completion28 Feb 2024
  4. Study completion31 May 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
21 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06173635
Sponsor's protocol ID
MaxiMove5-MACC-001-2023
Status last verified
Aug 2024
First submitted
23 Oct 2023
Last updated
14 Aug 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Maxi Move 5 in people with Healthy Volunteers, run by Arjo AB at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Aug 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

1. Time to complete each transfer will be recorded (time frame: up to 24 months). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Aug 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
A Comparison Study of the Maxi Move 5 (MM5) Device | AzTrials